Latest tumor Stories
Cedars-Sinai animal study may lead to human trial of experimental, compact intraoperative device to aid removal of malignant brain tumors
Company Supports March's Colorectal Cancer Awareness Month by Participating in the One Million Strong Screening Event in New York City on March 3 MADISON, N.J., Feb.
Cancer cells have long been known to have higher rates of the energy-generating metabolic pathway known as glycolysis.
SOUTH SAN FRANCISCO, Calif., Feb.
The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project has identified the most common genetic alteration ever reported in the brain tumor ependymoma and evidence that the alteration drives tumor development.
Cancer cell spread to the sentinel node—the lymph node to which cancer cells are most likely to spread from a primary tumor—is a risk factor for melanoma death.
Clinical and Regulatory Plans for Two Lead Products Announced SAN DIEGO, Feb.
US and Japanese patents cover the Company's whole slide imaging and analysis platform, which simultaneously measures tumor, immune, and stromal cells, processes, and biomarkers on a single specimen PITTSBURGH,
- A political dynamiter.